NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
Proton Pump Inhibitors: Risk of Erectile Dysfunction |
Levetiracetam and Clobazam: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) |
Hydrochlorothiazide: Risk of Acute Respiratory Distress Syndrome (ARDS) |
Ciprofloxacin, Moxifloxacin, Levofloxacin and Ofloxacin (Fluoroquinolones) for Systemic Use (Oral and Injection): Risk of Suicidal Behaviours |
|
10 Jul 2024; 08:00AM - 05:00PM MOPI Training 2024: Introduction to Laboratory Controls and analytical Method validation – managing OOS/ OOT/ OOE, Basics about Analytical Method Validation |
25 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Process Validation and application of Statistics in Validation |
11 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Computer Systems for Regulated Environment |
15 May 2024; 08:30AM - 01:00PM [INVITATION] SEMINAR: ISPE Online GDP Seminar : Module 2 (Validation & Self-Inspection Requirement for GDP Compliance) |
07 May 2024; 08:00AM - 05:00PM MOPI Training 2024: |